Leveljump Receives Approval For Listing Of Warrants On TSX Venture
Leveljump Healthcare (TSXV: JUMP) this morning has seen the TSX Venture approve the previously announced listing of certain outstanding warrants. The listed warrants are believed to trade under the symbol “JUMP.WT” on the exchange once listing is complete.
Warrants that are set to be listed are valid until December 14, 2023, which is 36 months from the listing of the original Leveljump common shares. Each warrant contains an exercise price of $0.50 per common share.
A total of up to 10.5 million common share purchase warrants are expected to be listed for trading as a result of the approval, bringing additional liquidity to the firms equity. 8.97 million warrants are expected to be listed initially, in connection with the firms qualifying transaction conducted late last year. A further 0.8 million are to be listed upon the conclusion of certain escrow conditions, while 0.7 million more are available to be listed following the exercise of certain options.
Leveljump Healthcare last traded at $0.335 on the TSX Venture.
FULL DISCLOSURE: Leveljump Healthcare Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Leveljump Healthcare Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
